 MALVERN, Pa., March 09, 2022 GLOBE NEWSWIRE -- Ocugen, Inc. NASDAQ: OCGN, a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19, today announces that Dr. Shankar Musunuri, Chairman, CEO and Co-Founder of Ocugen, Inc., will be presenting at the 34th Annual Roth Conference. 